PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-100.00%
Revenue decline while CX shows 13.06% growth. Joel Greenblatt would examine competitive position erosion.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Gross profit decline while CX shows 23.58% growth. Joel Greenblatt would examine competitive position.
-100.00%
Margin decline while CX shows 9.30% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-354.73%
EBITDA decline while CX shows 75.20% growth. Joel Greenblatt would examine position.
-100.00%
EBITDA margin decline while CX shows 54.97% growth. Joel Greenblatt would examine position.
-354.73%
Operating income decline while CX shows 70.77% growth. Joel Greenblatt would examine position.
-100.00%
Operating margin decline while CX shows 51.04% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-26.79%
Tax expense reduction while CX shows 95.05% growth. Joel Greenblatt would examine advantage.
26.79%
Net income growth while CX declines. John Neff would investigate advantages.
-100.00%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-100.00%
Both companies show declining EPS. Martin Whitman would check industry conditions.
-100.00%
Both companies show declining diluted EPS. Martin Whitman would check industry conditions.
-100.00%
Share count reduction while CX shows 0.00% change. Joel Greenblatt would examine strategy.
-100.00%
Diluted share reduction while CX shows 0.00% change. Joel Greenblatt would examine strategy.